Document is current
Any future updates will be listed below
-
Authors
Schrepf, Andrew
Kaplan, Chelsea M.
Ichesco, Eric
Larkin, Tony
Harte, Steven E.
Harris, Richard E.
Murray, Alison D. https://orcid.org/0000-0003-4915-4847
Waiter, Gordon D.
Clauw, Daniel J.
Basu, Neil
- License Information
-
More Information
Article History
Received: 27 November 2017
Accepted: 14 May 2018
First Online: 8 June 2018
Competing interests
: Pfizer provided supplementary funding to N.B. for data acquisition. D.J.C. has consulted or served as an expert witness for Forest Laboratories, Pfizer, Inc, Cerephex Corp, Eli Lilly and Company, Merck & Co, Nuvo Research Inc, Tonix Pharmaceuticals, Johnson & Johnson, Pierre Fabre, Cypress Biosciences, Wyeth Pharmaceuticals, UCB, AstraZeneca, Jazz Pharmaceuticals, Abbott Laboratories, and Iroko Pharmaceuticals. R.E.H. has consulted for Pfizer, Inc. S.E.H. has received research funding from Aptinyx, Cerephex, Eli Lily, Forest Laboratories, and Merck and served as a consultant for Pfizer, Analgesic Solutions, Aptinyx, and deCode Genetics. A.S., C.M.K., S.E.H., R.E.H., T.L., E.I., and D.J.C. have all received funding from the National Institutes of Health. The remaining authors declare no competing interests.
